Global Coronary Artery Bypass Grafts (CABG) Competitive Landscape Professional Research Report 2025
Research SummaryCoronary Artery Bypass Grafts (CABG) is a surgical procedure used to treat coronary artery disease, a condition where the blood vessels that supply oxygen-rich blood to the heart muscle become narrowed or blocked due to the buildup of plaque. During the CABG procedure, a cardiothoracic surgeon takes a healthy blood vessel, often from the chest, leg, or arm, and grafts it onto the blocked coronary artery, bypassing the narrowed or blocked segment. This creates a new pathway for blood flow to reach the heart muscle, improving blood supply and relieving symptoms such as chest pain (angina) and reducing the risk of heart attack. CABG is typically recommended for patients with severe coronary artery disease when other treatment options, such as medication or angioplasty, are not sufficient. It is a major surgical procedure that requires anesthesia and hospitalization, but it can significantly improve heart function and quality of life for patients with advanced coronary artery disease.
According to DIResearch's in-depth investigation and research, the global Coronary Artery Bypass Grafts (CABG) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Coronary Artery Bypass Grafts (CABG) include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, Stryker, Edwards Lifesciences, Genesee Biomedical, Karl Storz GmbH etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Coronary Artery Bypass Grafts (CABG). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Coronary Artery Bypass Grafts (CABG) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Coronary Artery Bypass Grafts (CABG) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Coronary Artery Bypass Grafts (CABG) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Coronary Artery Bypass Grafts (CABG) Include:
Medtronic
Getinge Group
LivaNova
Terumo
Boston Scientific
Stryker
Edwards Lifesciences
Genesee Biomedical
Karl Storz GmbH
Coronary Artery Bypass Grafts (CABG) Product Segment Include:
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Others
Coronary Artery Bypass Grafts (CABG) Product Application Include:
Traditional CABG
Nontraditional CABG
Chapter ScopeChapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Coronary Artery Bypass Grafts (CABG) Industry PESTEL Analysis
Chapter 3: Global Coronary Artery Bypass Grafts (CABG) Industry Porter’s Five Forces Analysis
Chapter 4: Global Coronary Artery Bypass Grafts (CABG) Major Regional Market Size and Forecast Analysis
Chapter 5: Global Coronary Artery Bypass Grafts (CABG) Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Coronary Artery Bypass Grafts (CABG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Coronary Artery Bypass Grafts (CABG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Coronary Artery Bypass Grafts (CABG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Coronary Artery Bypass Grafts (CABG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Coronary Artery Bypass Grafts (CABG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Coronary Artery Bypass Grafts (CABG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Coronary Artery Bypass Grafts (CABG) Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources